- Topics, Trends & Updates for December (12/2/22)
- New Guideline: Second-Line ART After Treatment Failure or for Regimen Simplification (11/29/22)
- Topics, Trends & Updates for November (11/10/22)
- Updated: Prevention and Management of HPV Infection in Adults With HIV (11/4/22)
- Updated: ART Drug-Drug Interactions (10/17/22)
- Topics, Trends & Updates for October (10/13/22)
- New Guideline: HCV Screening, Testing, and Diagnosis in Adults (10/6/22)
- NYSDOH Statement on Mpox Name Change (12/1/22)
- WHO Recommends New Name for Monkeypox Disease (11/30/22)
- NYCDOHMH: Novavax COVID-19 Boosters Allowed for People Ages 18 Years and Older (11/1/22)
- NYCDOHMH: Considerations for Monkeypox and Pregnant, Recently Pregnant, and Breastfeeding Patients (10/19/22)
- NYCDOHMH: Bivalent COVID-19 Booster Recommendation Expanded to Include Children Ages 5 to 11 Years (10/15/22)
- New NYS Regulation: Minor Consent Allowed for Monkeypox Services (10/14/22)
- FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups (10/12/2022)
- New Videos from NIDA: At the Intersection: HIV & Substance Use Research (12/2/22)
- CEI Newsletter (11/22/22)
- AETC NCRC: November 2022 Monthly Update (11/14/22)
- NYS Medicaid Update – October 2022 (11/9/22)
- NYSDOH AI Dear Colleague Letter: No Out of Pocket Costs for PrEP (10/25/22)
- PrEP Aware Week Starts October 24th! (10/14/22)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (10/11/22)
The New York State Department of Health (NYSDOH) AIDS Institute (AI) Clinical Guidelines Program is a longstanding, collaborative effort of the AI Office of the Medical Director and the Johns Hopkins University School of Medicine, Division of Infectious Diseases.
The program produces and publishes evidence-based, state-of-the-art clinical practice guidelines that establish uniform standards of care for NYS to improve the health and well-being of all adults who receive prevention services or treatment for HIV, viral hepatitis, other sexually transmitted infections, and substance use disorders.
Learn more: